High insulin prices spur a federal lawsuit against three pharmacy benefit managers
Published on: 09/20/2024
This news was posted by Oregon Today News
Description
The FTC said the rebating practices of three companies — Caremark, Express Scripts and OptumRx — have led to artificially inflated list prices.
Other Related News
09/20/2024
The 18-year-old charged in the fatal shooting made his first court appearance FridayTheyve...
09/20/2024
LaToya Hills fianc stated that Gates knew their family well and had a brother who once liv...
09/20/2024
Residential wells supporting hundreds of eastern Oregon households are unusable due to uns...
09/20/2024
httpscsd8-mysharepointcomvgpersonalpyicoquillek12orusEdNA3ZIIfBpLnDXG2yZ1MS8B1Q5plyLXIS4Rd...
09/20/2024